BEAMSTART Logo

Paris MedTech AQEMIA expands to London as funding tops $100m

BusinessCloud LogoBusinessCloud1d ago

Paris MedTech AQEMIA expands to London as funding tops $100m - BusinessCloud

Quick Summary:

It also has a $140m collaboration with Sanofi, announced in December 2023.

It is now scheduled to open a London office in the King’s Cross area in January 2025.

With this momentum, we are poised to advance to clinical trials, bringing us closer to delivering life-changing treatments to patients in need.


More Pictures

Paris MedTech AQEMIA expands to London as funding tops $100m - BusinessCloud (Picture 1)

or

Article Details

Author / Journalist: Jonathan Symcox

Category: InvestingBusiness

Markets:

Topics:

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-12-11 @ 09:23:43 (1 days ago)

News Timezone: GMT +8:00

News Source URL: businesscloud.co.uk

Language: English

Article Length: 333 words

Reading Time: 2 minutes read

Sentences: 8 lines

Sentence Length: 42 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © BusinessCloud

News ID: 24352565

View Article Analysis

About BusinessCloud

BusinessCloud Logo

Main Topics: InvestingBusiness

Official Website: businesscloud.co.uk

Year Established: 2016

Headquarters: United Kingdom

News Last Updated: 1 days ago

Coverage Areas: United Kingdom

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #61

Publisher Details

Frequently Asked Questions

How long will it take to read this news story?

The story "Paris MedTech AQEMIA expands to London as funding tops $100m" has 333 words across 8 sentences, which will take approximately 2 - 3 minutes for the average person to read.

Which news outlet covered this story?

The story "Paris MedTech AQEMIA expands to London as funding tops $100m" was covered 1 days ago by BusinessCloud, a news publisher based in United Kingdom.

How trustworthy is 'BusinessCloud' news outlet?

BusinessCloud is a fully independent (privately-owned) news outlet established in 2016 that covers mostly investing and business news.

The outlet is headquartered in United Kingdom and publishes an average of 0 news stories per day.

It's most recent story was published 1 days ago.

What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #24352565
  • URL: https://beamstart.com/news/paris-medtech-aqemia-expands-to-17339179247115

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2024 BEAMSTART. All Rights Reserved.